Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$4.5M
-61.7% from 2023
Prescriptions
56K
$81.46 per claim
Patients
35K
27,487 prescribers
Total spending, 2024
$4.5M
$131.18 per patient
Medicare prescription drug plans paid $4.5M for Proair Respiclick in 2024, for 55,759 prescriptions and refills to 34,633 patients (down 61.7% from 2023). The average cost per claim was $81.46.
California had the highest Medicare cost for Proair Respiclick in 2024: $494K for 6,282 claims, followed by Florida ($364K).
Samuel A Amill-Acosta, pulmonary disease in Manati, PR, had the highest Medicare cost for Proair Respiclick in 2024: 661 claims costing $47K.
Proair Respiclick is made by Teva Pharmaceutical Industries Limited (TEVA), listed in the Medicare spending data as Teva Specialty.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Samuel A Amill-Acosta Manati, PR | Pulmonary Disease | 661 | 213 | $47K |
| Luis C Torrellas Ruiz Humacao, PR | Pulmonary Disease | 228 | 71 | $16K |
| Pedro A Torrellas Ruiz |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 35,432 | 87,474 | 46,670 | $7.9M |
| 2023 | 45,039 | 124,055 | 61,786 | $11.9M |
| 2024 | 27,487 | 55,759 | 34,633 | $4.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 58 |
| 21 |
| $4,068 |
| Shelly Vroman Orion, IL | Nurse Practitioner | 30 | Under 11 | $3,536 |
| Jack M Kanoff Hammonton, NJ | Pulmonary Disease | 17 | Under 11 | $3,500 |
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 48 | 21 | $3,235 |
| Larry R Levine Dunedin, FL | General Practice | 40 | 22 | $3,141 |
| Wisam S Naji Valencia, CA | Internal Medicine | 48 | 24 | $3,129 |
| George Poiani Bridgewater, NJ | Pulmonary Disease | 20 | 14 | $2,935 |
| Clint T Pearson Crescent City, CA | Family Practice | 32 | Under 11 | $2,697 |
| Ladly Abraham Conway, AR | Pulmonary Disease | 37 | 32 | $2,514 |
| Armando O Cardona-Ramirez Mayaguez, PR | Pulmonary Disease | 35 | 11 | $2,455 |
| Jeffrey A Miller East Orange, NJ | Pulmonary Disease | 34 | 13 | $2,446 |
| Leanne K Strack Sandusky, OH | Pulmonary Disease | 23 | Under 11 | $2,412 |
| Rajeev Yelamanchili Apple Valley, CA | Pulmonary Disease | 26 | Under 11 | $2,376 |
| Fabrizio Monge Punta Gorda, FL | Pulmonary Disease | 14 | Under 11 | $2,367 |
| Fateh U Ahmed Toledo, OH | Pulmonary Disease | 18 | 12 | $2,220 |
| John T Sentz Richmond, VA | Internal Medicine | 34 | Under 11 | $2,203 |
| Kaiser Toosy New Haven, CT | Pulmonary Disease | 12 | Under 11 | $2,146 |
| Michael E Flatley West Allis, WI | Pulmonary Disease | 16 | Under 11 | $2,132 |
| James M Orrell Marion, IN | Family Practice | 15 | Under 11 | $2,105 |
| Wassim Shwaiki Munster, IN | Pulmonary Disease | 13 | Under 11 | $2,026 |
| Sammy T Hung Hayward, CA | Pulmonary Disease | 15 | Under 11 | $2,014 |
| Julie H Yoo Fullerton, CA | Pulmonary Disease | 16 | 15 | $1,976 |
| Matthew R Montoya Albuquerque, NM | Pulmonary Disease | 15 | Under 11 | $1,970 |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Teva Specialty TEVA | 55,802 | $4.5M |